The effect of hrHPV prevalence on cervical cancer screening strategies: a cost-effectiveness study of Bangladesh

Fengming Pan; Jurjen van der Schans; Naheed Nazrul; Jaap A. R. Koot; Jogchum Beltman; Marcel J. W. Greuter; Geertruida H. de Bock

doi:10.1186/s12889-025-21756-x

The effect of hrHPV prevalence on cervical cancer screening strategies: a cost-effectiveness study of Bangladesh

Fengming Pan^*, Jurjen van der Schans, Naheed Nazrul, Jaap A. R. Koot, Jogchum Beltman, Marcel J. W. Greuter, Geertruida H. de Bock

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Article number	561
Number of pages	11
Journal	BMC Public Health
Volume	25
Issue number	1
DOIs	https://doi.org/10.1186/s12889-025-21756-x
Publication status	Published - 11 Feb 2025

Keywords

Bangladesh
Cost-effectiveness analysis
Human papillomavirus DNA tests
Prevalence

Access to Document

10.1186/s12889-025-21756-xLicence: CC BY

Cite this

@article{ed915b13c26148e683a994617461ec75,

title = "The effect of hrHPV prevalence on cervical cancer screening strategies: a cost-effectiveness study of Bangladesh",

keywords = "Bangladesh, Cost-effectiveness analysis, Human papillomavirus DNA tests, Prevalence",

author = "Fengming Pan and {van der Schans}, Jurjen and Naheed Nazrul and Koot, {Jaap A. R.} and Jogchum Beltman and Greuter, {Marcel J. W.} and {de Bock}, {Geertruida H.}",

year = "2025",

month = feb,

day = "11",

doi = "10.1186/s12889-025-21756-x",

language = "English",

volume = "25",

journal = "BMC Public Health",

issn = "1471-2458",

publisher = "BioMed Central Ltd.",

number = "1",

}

TY - JOUR

T1 - The effect of hrHPV prevalence on cervical cancer screening strategies

T2 - a cost-effectiveness study of Bangladesh

AU - Pan, Fengming

AU - van der Schans, Jurjen

AU - Nazrul, Naheed

AU - Koot, Jaap A. R.

AU - Beltman, Jogchum

AU - Greuter, Marcel J. W.

AU - de Bock, Geertruida H.

PY - 2025/2/11

Y1 - 2025/2/11

KW - Bangladesh

KW - Cost-effectiveness analysis

KW - Human papillomavirus DNA tests

KW - Prevalence

U2 - 10.1186/s12889-025-21756-x

DO - 10.1186/s12889-025-21756-x

M3 - Article

C2 - 39934769

SN - 1471-2458

VL - 25

JO - BMC Public Health

JF - BMC Public Health

IS - 1

M1 - 561

ER -